{"cik":1581178,"taxonomy":"us-gaap","tag":"NetIncomeLoss","label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","entityName":"EUPRAXIA PHARMACEUTICALS INC.","units":{"USD":[{"start":"2022-01-01","end":"2022-12-31","val":-18489629,"accn":"0001193125-24-083584","fy":2023,"fp":"FY","form":"40-F","filed":"2024-04-01","frame":"CY2022"},{"start":"2023-01-01","end":"2023-12-31","val":-28220796,"accn":"0001193125-24-083584","fy":2023,"fp":"FY","form":"40-F","filed":"2024-04-01"},{"start":"2023-01-01","end":"2023-12-31","val":-28220796,"accn":"0001193125-25-059352","fy":2024,"fp":"FY","form":"40-F","filed":"2025-03-20","frame":"CY2023"},{"start":"2024-01-01","end":"2024-12-31","val":-25502536,"accn":"0001193125-25-059352","fy":2024,"fp":"FY","form":"40-F","filed":"2025-03-20"},{"start":"2024-01-01","end":"2024-12-31","val":-25502536,"accn":"0001193125-26-104765","fy":2025,"fp":"FY","form":"40-F","filed":"2026-03-13","frame":"CY2024"},{"start":"2025-01-01","end":"2025-12-31","val":-38576143,"accn":"0001193125-26-104765","fy":2025,"fp":"FY","form":"40-F","filed":"2026-03-13","frame":"CY2025"}]}}